West Pharmaceutical Services, Inc.
WST Healthcare Medical Instruments & Supplies
West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024.
- Revenue
- +8.69%
- EPS
- +56.7%
- Free cash flow
- +12.3%
- Total debt
- +0.10%
Quarter to September 2026, against a year earlier
Follow WST
Alert me
West Pharmaceutical Services, Inc. (WST) Current ratio
West Pharmaceutical Services, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 2.8×, down 0.2× from fiscal 2025 (3.0×). Over the past ten years it has ranged from 2.1× (fiscal 2015) to 3.7× (fiscal 2022); the current reading is higher than 73% of that period. That is above the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 3.0× | 8.09% |
| FY2024 | 2.8× | (3.05%) |
| FY2023 | 2.9× | (22.07%) |
| FY2022 | 3.7× | 26.13% |
| FY2021 | 2.9× | 7.45% |
| FY2020 | 2.7× | (11.95%) |
| FY2019 | 3.1× | (1.69%) |
| FY2018 | 3.2× | 18.51% |
| FY2017 | 2.7× | (0.13%) |
| FY2016 | 2.7× | 24.26% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 2.8× | (0.10%) |
| Jun 2026 | 2.8× | 4.12% |
| Mar 2026 | 2.7× | (10.27%) |
| Dec 2025 | 3.0× | 5.27% |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| MDLN Medline Inc. compare | 4.0× |
| WST West Pharmaceutical Services, Inc. | 2.8× |
| RMD ResMed Inc. compare | 2.6× |
| ALC Alcon compare | 2.1× |
| BAX Baxter International Inc. compare | 1.8× |
| ALGN Align Technology, Inc. compare | 1.4× |
| COO The Cooper Companies, Inc. compare | 1.2× |
| SOLV Solventum Corporation compare | 1.0× |
| BDX Becton, Dickinson and Company compare | 0.9× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on WST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement